As of 2024-12-13, the Relative Valuation of SpectraCure AB (publ) (SPEC.ST) is (6.67) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 1.30 SEK, the upside of SpectraCure AB (publ) based on Relative Valuation is -614.0%.
The range of the Relative Valuation is (5.69) - (8.22) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 29.6x | 23.4x |
| Forward P/E multiples | 18.2x - 32.4x | 24.6x |
| Fair Price | (5.69) - (8.22) | (6.67) |
| Upside | -538.2% - -733.1% | -614.0% |
| Date | P/E |
| 2024-12-10 | -4.67 |
| 2024-12-09 | -3.66 |
| 2024-12-06 | -4.18 |
| 2024-12-05 | -4.63 |
| 2024-12-04 | -4.38 |
| 2024-12-03 | -4.31 |
| 2024-12-02 | -4.37 |
| 2024-11-29 | -5.21 |
| 2024-11-28 | -5.19 |
| 2024-11-27 | -5.57 |
| 2024-11-26 | -5.93 |
| 2024-11-25 | -6.07 |
| 2024-11-22 | -5.92 |
| 2024-11-21 | -5.69 |
| 2024-11-20 | -5.83 |
| 2024-11-19 | -5.74 |
| 2024-11-18 | -5.86 |
| 2024-11-15 | -5.97 |
| 2024-11-14 | -6.12 |
| 2024-11-13 | -5.15 |
| 2024-11-12 | -5.04 |
| 2024-11-11 | -5.15 |
| 2024-11-08 | -5.76 |
| 2024-11-07 | -4.82 |
| 2024-11-06 | -4.73 |
| 2024-11-05 | -5.00 |
| 2024-11-04 | -5.53 |
| 2024-11-01 | -5.75 |
| 2024-10-31 | -5.97 |
| 2024-10-30 | -6.27 |
| 2024-10-29 | -6.40 |
| 2024-10-28 | -6.55 |
| 2024-10-25 | -6.65 |
| 2024-10-24 | -6.82 |
| 2024-10-23 | -6.25 |
| 2024-10-22 | -6.58 |
| 2024-10-21 | -6.65 |
| 2024-10-18 | -6.97 |
| 2024-10-17 | -7.12 |
| 2024-10-16 | -7.05 |
| 2024-10-15 | -7.17 |
| 2024-10-14 | -7.25 |
| 2024-10-11 | -7.37 |
| 2024-10-10 | -7.14 |
| 2024-10-09 | -7.21 |
| 2024-10-08 | -7.30 |
| 2024-10-07 | -7.32 |
| 2024-10-04 | -7.28 |
| 2024-10-03 | -7.37 |
| 2024-10-02 | -7.32 |